WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
Position in JNJ — Johnson & Johnson
CIK 1632972
PLYMOUTH, MN
Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$465,733,487
+$85,461,357 QoQ
Shares Held
1,833,813
+17.9% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
1.54%
of 13F equity value
Holder Rank
#112
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Sep 30, 2024CallValue
$0
CallShares
0
PutValue
$18,433
PutShares
8,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $1,542,735,587 across 15 Drug Manufacturers - General names. JNJ ranks #1 (30.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
1,833,813 | $465,733,487 | |
| 2 | LLY |
ELI LILLY & Co
|
183,702 | $220,337,708 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,625,531 | $208,880,733 | |
| 4 | AMGN |
Amgen Inc
|
464,220 | $168,103,346 | |
| 5 | ABBV |
AbbVie Inc.
|
576,543 | $145,081,280 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,764,695 | $101,681,725 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
603,836 | $76,288,640 | |
| 8 | PFE |
Pfizer Inc
|
3,158,575 | $76,058,486 |
All Filings in JNJ
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $465,733,487 | 1,833,813 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $380,272,130 | 1,555,687 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $400,818,276 | 1,936,788 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $341,992,541 | 1,844,421 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $263,354,136 | 1,724,086 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $281,734,133 | 1,698,831 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $231,424,105 | 1,600,222 | Shares | Sole | 2025-03-17 | |
| 2024-09-30 | $215,362,992 | 1,328,909 | Shares | Sole | 2024-10-24 | |
| 2024-09-30 | $18,433 | 8,400 | Put | Sole | 2024-10-24 | |
| 2024-06-30 | $185,445,030 | 1,268,781 | Shares | Sole | 2024-07-16 | |
| 2024-06-30 | $17,851 | 4,200 | Put | Sole | 2024-07-16 | |
| 2024-03-31 | $11,705 | 4,200 | Put | Sole | 2024-04-15 | |
| 2024-03-31 | $193,368,292 | 1,222,380 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $20,915 | 4,200 | Put | Sole | 2024-01-30 | |
| 2023-12-31 | $185,398,184 | 1,182,839 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $178,806,295 | 1,148,034 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $23,149,296 | 139,858 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $21,594,290 | 139,318 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $15,201,085 | 86,052 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $2,624,705 | 16,067 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $915,419 | 5,157 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $2,457,825 | 13,868 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $2,526,874 | 14,771 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $839,315 | 5,197 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $10,513,212 | 63,817 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,259,319 | 13,747 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,045,467 | 12,997 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $6,842,375 | 45,959 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,074,774 | 36,086 | Shares | Sole | 2020-10-13 | |
| 2020-03-31 | $6,031,455 | 45,996 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||